FOXO TECHNOLOGIES INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
FOXO TECHNOLOGIES INC. (FOXO) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.10% for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-04-15
- FOXO TECHNOLOGIES INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.10%, a 0.00% change from fiscal 2022.
- FOXO TECHNOLOGIES INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 0.10%.
- FOXO TECHNOLOGIES INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -0.10%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2023-12-31 | 0.10% 10-K · filed 2025-04-15 | |
| 2022-12-31 | 0.10% 10-K · filed 2024-06-06 | -0.10% 10-K · filed 2023-03-31 |
| 2021-12-31 | -0.10% 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |